Seeing Is Believing
Currently out of the existing stock ratings of Luca Issi, 115 are a HOLD (34.64%), 217 are a BUY (65.36%).
Analyst Luca Issi, currently employed at RBC, carries an average stock price target met ratio of 53.87% that have a potential upside of 46.37% achieved within 218 days.
Luca Issi’s has documented 634 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Communication Services, Technology sectors.
Most recent stock forecast was given on ARGX, argenx NV ADR at 07-Jul-2026.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 6/28/2021. The price target of $150 was fulfilled within 1 day with a profit of $16.57 (12.42%) receiving and performance score of 124.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Apr-2023
$11
$8.87 (416.43%)
$12
2 months 28 days ago
(16-Apr-2026)
0/12 (0%)
$8.63 (364.14%)
Hold Since 21-Mar-2023
$3.85
$1.72 (80.75%)
$2.5
3 months ago
(14-Apr-2026)
2/3 (66.67%)
$1.13 (41.54%)
155
Buy Since 14-May-2025
$9
$6.87 (322.54%)
$9
3 months ago
(14-Apr-2026)
1/4 (25%)
$6.28 (230.88%)
19
Buy Since 05-Nov-2018
$8
$5.87 (275.59%)
4 months 1 days ago
(13-Mar-2026)
2/7 (28.57%)
$5.6 (233.33%)
3
Buy Since 04-Nov-2019
4 months 1 days ago
(13-Mar-2026)
1/2 (50%)
$28.66 (452.05%)
192
Which stock is Luca Issi is most bullish on?
Which stock is Luca Issi is most reserved on?
What Year was the first public recommendation made by Luca Issi?